B

OSTON (FINALLY) — I slept little, ate poorly, drank moderately, and didn’t exercise, save for a single walk up a big hill with Luke Timmerman. I attended meetings, presentations, and breakouts. It rained a lot. I talked to lots of people. I was asked, “How’s your meeting going?” 7,568 times. I wrote some words and tweeted. I lived in a rented house with six STAT co-workers and brewed an insane amount of coffee.

I flew to San Francisco with some burning biotech questions on my mind. Now that the J.P. Morgan Healthcare Conference 2018 is in the books, here are some of the burning answers.

Unlock this article by subscribing to STAT Plus today. Try it FREE for 30 days and cancel anytime!

SUBSCRIBE TODAY

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.

Privacy Policy